Biocryst Pharmaceuticals (BCRX) Work In Process (2015 - 2017)

Biocryst Pharmaceuticals has reported Work In Process for 3 years, with the latest figure at $1.3 million in Q2 2017.

• For the quarter ending Q2 2017, Work In Process fell 33.04% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2017 stood at $1.3 million (down 33.04% YoY), and the FY2016 full-year result was $500000.0, down 68.98% from the prior year.
• Work In Process for Q2 2017 stood at $1.3 million, up from $655000.0 in the prior quarter.
• The five-year high for Work In Process was $2.2 million in Q3 2016, with the low at $500000.0 in Q4 2016.
• Historically, Work In Process has averaged $1.5 million across 3 years, with a median of $1.6 million in 2015.
• Annual changes were most pronounced in 2016 — Work In Process slumped 68.98% — and 2017, when it plunged 33.04%.
• Biocryst Pharmaceuticals' Work In Process stood at $1.6 million in 2015, then plunged by 68.98% to $500000.0 in 2016, then jumped by 161.0% to $1.3 million in 2017.
• The last three Work In Process figures came in at $1.3 million (Q2 2017), $655000.0 (Q1 2017), and $500000.0 (Q4 2016), per Business Quant data.